|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/14 | |
| A61K 31/5365 | |||
| A61P 31/18 | |||
| A61P 31/12 |
| (11) | Number of the document | 2742051 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12831486.1 |
| Date of filing the European patent application | 2012-09-02 | |
| (97) | Date of publication of the European application | 2014-06-18 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2012/050344 |
| Date | 2012-09-02 |
| (87) | Number | WO 2013/038407 |
| Date | 2013-03-21 |
| (30) | Number | Date | Country code |
| 201161534395 P | 2011-09-14 | US |
| (72) |
MAROM, Ehud, IL
RUBNOV, Shai, IL
|
| (73) |
Mapi Pharma Limited,
16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona,
IL
|
| (54) | Amorphous form of the dolutegravir sodium salt |
| Amorphous form of the dolutegravir sodium salt |